Latham & Watkins and Morgan Lewis & Bockius represented Mylan in the dispute. The Third Circuit on Thursday backed a finding that generic-drug maker Mylan was...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented SK Capital Partners in the fundraising. SK Capital Partners, LP has announced the close of SKCP Catalyst Fund II. The fund was...
You must be a Standard 1 Year member to access this content.
Latham and Watkins advised Transcend on the financing. Transcend Software Inc. announced it has closed on its Series B financing round with participation from Autodesk, Inc., a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised Igneo on the sale. AXA IM Alts has announced it has entered into an agreement to acquire a 25% stake in Iberian...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented ConocoPhillips on the deal. Mexico Pacific and ConocoPhillips (NYSE: COP) announced that they have signed sales and purchase agreements for ConocoPhillips to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised BPEA EQT Funds V and VI and portfolio company Vistra on the deal, while Ropes & Gray advised BPEA Private Equity Fund...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the placement agents in the offering. UroGen Pharma Ltd. (Nasdaq: URGN) announced that it has entered into a definitive securities purchase agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised SiteMinder on the financing. SiteMinder announced a financing consisting of a $20 million revolving credit facility. HSBC Ventures USA Inc. acted as...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised PROCEPT BioRobotics, and Shearman & Sterling advised the underwriters. PROCEPT BioRobotics Corporation announced a follow-on offering of 5,085,494 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Origis Energy on the financing. Origis Energy announced the close of an upsizing amendment to their development finance facility doubling capacity to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Vertiv ; and Simpson Thacher & Bartlett represented the sole underwriter, BofA Securities in the offering. Vertiv Holdings Co (Vertiv) (NYSE: VRT)...
You must be a Standard 1 Year member to access this content.
